Purchase Order 75N94025P00487
Award Date
8/12/25
Potential Completion Date
10/12/25
Potential Value
$12K
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order for $50,445.50 was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency of the U.S. government, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of reagent kits and has a completion date of September 29, 2023. The contract was competitively awarded with no set-aside designation. Illumina has previously provided...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The $99,745.80 firm fixed price delivery order contract is for the provision of various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with supporting reagents, consumables, and services. The contract does not have a set-aside designation....
This firm fixed-price delivery order contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $76,500.00 contract provides Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics...
This is a delivery order awarded by the National Institute on Aging, a civilian agency, to Illumina, Inc., a for-profit organization and manufacturer of genetic sequencing instruments and reagents. The $30,671.68 firm fixed price contract is for the provision of NovaSeq 6000 S4 reagent kits, which are used in Illumina's high-throughput sequencing systems. The contract has no set-aside designation and an ultimate completion date of September 5, 2024. Illumina has a history of providing sequencing...
This is a firm fixed price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The contract, valued at $80,449.94, is for the provision of Illumina's sequencing and analytical instruments and reagents to support NIDDK's genomic research and diagnostics efforts. The contract has no set-aside designation. Illumina has previously been awarded prime...
This federal contract award was issued by the National Institute on Aging, a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $88,513.40 firm fixed price delivery order is for Illumina's NovaSeq 6000 S4 reagent kits, which are used for 300-cycle sequencing runs. This award is not associated with a set-aside program. Through prior federal contracts, Illumina has provided a range of sequencing systems, consumables, and services to...
This is a firm fixed-price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $248,854.86 contract is for the procurement of NovaSeq X Series reagent kits, including 1.5B, 25B, and 10B cycle kits, to support genomic research and diagnostic applications. The contract does not have a set-aside designation. Illumina has been...
This is a $19,812.90 firm fixed-price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract has an ultimate completion date of August 3, 2026 and was awarded on August 4, 2025. No set-aside designation was used. Illumina, a leading provider of DNA and RNA sequencing technologies, will deliver a range...
This is a $5,216.64 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. for the provision of sequencing systems, reagents, and related services. The award has no set-aside designation. Illumina, a for-profit manufacturer, has previously supported genomic sequencing and analysis efforts across various federal agencies including the NIH, CDC, USDA,...
This is a firm fixed price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract has a ceiling value of $100,502.64 and a completion date of September 2, 2020. Illumina has provided various sequencing systems, reagents, consumables, and bioinformatics products to support genomic research and diagnostics for NIDDK...